Danone’s yogurt bounty can spur M&A spree
The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Jennifer Johnson
LONDON, Oct 24 (Reuters Breakingviews) -Danone DANO.PA has found a rare, sweet spot for consumer goods groups. The $47 billion dairy specialist is consistently hitting its sales targets and maintaining volumes, unlike rival Nestlé NESN.S. With its comparatively healthy offering playing well with consumers and a strong balance sheet, CEO Antoine de Saint-Affrique can afford to splurge.
The maker of Evian water and Activia yogurts has been on a winning streak of late. Back in February de Saint-Affrique announced plans to raise the dividend after the company delivered record free cash flow of 2.3 billion euros in 2023. On Thursday, Danone reported third-quarter sales were up 4.2% to nearly 7 billion euros, versus the same period last year. Though the dairy business contributed almost half of this total figure, the specialised nutrition division shined the brightest, with revenue up 5.2%.
De Saint-Affrique’s turnaround is clearly working. Since taking the helm in 2021 he has sold off two underperforming U.S. organic dairy businesses and promised to pivot further into high-protein and gut health categories. Thursday’s figures represent the sixth consecutive quarter of volume growth for Danone.
This success has also smartened up Danone’s balance sheet. At the end of June, Danone had 10 billion euros of net debt, or roughly twice its expected EBITDA for 2024, meaning it could make a 5 billion euro purchase and its leverage would still be comparable to Nestlé’s.
So far, de Saint-Affrique has been cautious on the deal front. The company attempted a further move into the gut-related dairy space in September with a $283 million bid for the remaining stake in U.S. kefir maker Lifeway Foods LWAY.O. Danone already owned 25% of the company. However, the French group can afford to be bolder and go after targets for its specialised nutrition business, which makes infant formula and foods for people with medical needs.
Danone's valuation suggests investors increasingly believe in dairy. The group trades on 17 times its expected earnings for 2024, a boost from last year when it traded on just 14.5 times. It is also closing the gap between Nestlé and Unilever ULVR.L which trade on 18 and 19 times, respectively. To close the remaining gap, Danone should find some appetising targets.
Follow @jenjohn_ on X
CONTEXT NEWS
Danone on Oct. 24 reported a 4.2% rise in third-quarter like-for-like sales to 6.8 billion euros ($7.36 billion), exceeding analysts' expectations of a 3.9% rise in a company-compiled consensus.
Sales volumes rose by 3.6% in the third quarter, compared to a 2.9% increase expected by analysts polled in a company-provided consensus.
Europe remained the group’s biggest market in the third quarter, with 2.4 billion euros of sales, while North American revenue was up almost 6% on a like-for-like basis to 1.6 billion euros.
The world's largest yoghurt maker kept its forecast for 2024 like-for-like sales growth of between 3% and 5%, with a moderate improvement in recurring operating margin.
Shares in Danone were up 2.8% by 0859 GMT on Oct. 24.
The valuation gap is narrowing between Europe's consumer health giants https://reut.rs/3UmjSiG
Editing by Aimee Donnellan and Streisand Neto
Aloqador aktivlar
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
